NEO/ZLLY (NEO/ZLLY)

Cboe Canada: NEO/ZLLY · CAD

CA$13.7

+0.14 (+1.0%)· Recorded snapshot

Market cap	1.6T
Revenue (ttm)	113.1B
Net income (ttm)	37.9B
EPS (ttm)	CA$0.31
P/E (trailing)	43.5x
P/E (forward)	33.6x
Dividend	CA$0.05 (0.38%)
Volume	1
Beta	0.45

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 113.1B
Net income (ttm): 37.9B
EPS (ttm): CA$0.31
P/E (trailing): 43.5x
P/E (forward): 33.6x
Market cap: 1.6T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E33.6

P25 n/aP50 n/aP75 n/a

Trailing P/E43.5

P25 n/aP50 n/aP75 n/a

ROE102.3

P25 n/aP50 n/aP75 n/a

ROIC42.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NEO/ZLLY indicators

Market & fundamental data

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	United States
Country code	CA
Earnings date	2026-10-29
Employees	50,000
Employees change	3,000
Employees growth	6.38%
Enterprise value	CAD 1.7T
Exchange	Cboe Canada
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1876
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	CA2869111021
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Market cap	CAD 1.6T
Next earnings date	2026-10-29
Price	CAD 13.69
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	neo/ZLLY
Website	https://www.lilly.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	52.78x
Average P/E ratio (3Y)	71.41x
Average P/E ratio (5Y)	62.99x
Earnings yield	2.3%
EV/Earnings	43.98x
EV/EBIT	29.99x
EV/EBITDA	28.34x
EV/FCF	64.58x
EV/Sales	14.91x
FCF / EV yield	1.55%
FCF yield	1.61%
Forward P/E	33.58x
Graham number	1.71087
Graham upside	-87.37%
Lynch fair value	CAD 8.01
Lynch upside	-40.91%
P/(FCF - SBC) ratio	64.43x
P/(OCF - SBC) ratio	41.19x
P/B ratio	33.36x
P/E ratio	43.48x
P/FCF ratio	62.13x
P/OCF ratio	40.24x
P/S ratio	14.19x
Price / tangible book value	163.31x
Price/EBITDA ratio	27.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	49.72%
EBITDA margin	52.35%
Effective tax rate	20.49%
FCF margin	23.06%
Gross margin	83.4%
Operating margin	49.72%
Pretax margin	42.17%
Profit margin	33.53%
Profit per employee	CAD 758,646
Profitable quarters	11
Profitable years	8
Revenue per employee	CAD 2.3M
ROA	20.36%
ROA (5Y)	13.51%
ROCE	41.89%
ROE	102.29%
ROE (5Y)	74.21%
ROIC	42.24%
ROIC (5Y)	35.51%
SBC / revenue	0.81%
Tax / revenue	8.64%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	94.8%
EPS growth (Q)	26.23%
EPS growth (QoQ)	-3.87%
EPS growth 10Y	29.08%
EPS growth 3Y	60.68%
EPS growth 5Y	34.97%
EPS growth quarters	11
EPS growth years	2
FCF growth	272.37%
FCF growth (Q)	458.06%
FCF growth (QoQ)	157.96%
FCF growth 3Y	69.77%
FCF growth 5Y	26.73%
Gross profit growth	50.96%
Gross profit growth (Q)	50.31%
Gross profit growth 3Y	42.51%
Gross profit growth 5Y	26.7%
Net income growth	93.56%
Net income growth (Q)	25.33%
Net income growth (QoQ)	-4.07%
Net income growth 3Y	60.19%
Net income growth 5Y	34.49%
Net income growth quarters	11
Net income growth years	2
OCF growth	156.73%
OCF growth (Q)	246.29%
OCF growth (QoQ)	100.45%
OCF growth 10Y	23.94%
OCF growth 3Y	65.09%
OCF growth 5Y	31.67%
Operating income growth	78.34%
Operating income growth (Q)	77.42%
Operating income growth 3Y	68.37%
Operating income growth 5Y	38.93%
Revenue growth	49.58%
Revenue growth (Q)	47.67%
Revenue growth (QoQ)	16.04%
Revenue growth 10Y	14.48%
Revenue growth 3Y	39.23%
Revenue growth 5Y	24.41%
Revenue growth quarters	13
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -14B
Depreciation and amortization	CAD 3B
EBIT	CAD 56.2B
EBITDA	CAD 59.2B
EPS	CAD 0.31
Financing cash flow	CAD 3.7B
Free cash flow	CAD 25.8B
Free cash flow minus SBC	CAD 24.9B
Gross profit	CAD 94.4B
Income taxes	CAD 9.8B
Investing cash flow	CAD -35.6B
Net borrowing	CAD 21.4B
Net cash flow	CAD 7.9B
Net income	CAD 37.9B
Operating cash flow minus SBC	CAD 39B
Operating income	CAD 56.2B
Revenue	CAD 113.1B
Stock-based compensation	CAD 921.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.55
Book value per share	CAD 53.97
Debt / EBITDA	1.31
Debt / equity	1.62
Debt / FCF	3.02
Goodwill	CAD 12.4B
Interest coverage	215.26
Long-term assets	CAD 111.1B
Long-term liabilities	CAD 86.8B
Net cash (debt)	CAD -64.1B
Net cash / market cap	-4%
Net debt / EBITDA	1.08
Net debt / equity	1.33
Net debt / FCF	2.48
Piotroski F-Score	7
Property, plant and equipment	CAD 41.2B
Shareholders' equity	CAD 48.1B
Tangible book value	CAD 9.8B
Tangible book value per share	CAD 11.02
Total assets	CAD 202.1B
Total cash	CAD 12.7B
Total debt	CAD 78B
Total liabilities	CAD 153.9B
WACC	6.44%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.66
Current assets	CAD 90.9B
Current liabilities	CAD 67.1B
Current ratio	1.35
Inventory turnover	0.95
Net working capital	CAD 21.3B
Quick ratio	0.68
Working capital	CAD 24B
Working capital turnover	8.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.62%
Dividend growth	0%
Dividend growth years	0
Dividend payment years	1
Dividend per share	CAD 0.05
Dividend yield	0.38%
Ex-dividend date	2026-05-15
Last dividend	CAD 0.02
Payout ratio	21.66%
Shareholder yield	1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 11.80
1D price change	1.03%
1M price change	12.12%
1M total return	12.12%
1W price change	0.74%
1W total return	0.74%
20-day SMA	CAD 13.00
200-day SMA	CAD 11.58
3M price change	8.39%
3M total return	8.39%
50-day SMA	CAD 12.62
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 13.87
52-week high date	2026-10-22
52-week low	CAD 9.09
52-week low date	2026-04-29
6M price change	41.87%
6M total return	41.87%
All-time high	CAD 13.87
All-time high date	2026-10-22
All-time low	CAD 9.09
All-time low date	2026-04-29
Average true range (ATR)	CAD 0.15
Average volume	324.5
Beta (5Y)	0.45
Change from 52-week high	-1.3%
Change from 52-week low	50.61%
Change from all-time high	-1.3%
Change from all-time low	50.61%
Change from open	0%
Day's gap	1.03%
Dollar volume	CAD 13.69
High price	CAD 13.69
Low price	CAD 13.69
Monthly RSI	0
Open price	CAD 13.69
Previous close	CAD 13.55
Price vs 150-day SMA	15.99%
Price vs 20-day SMA	5.32%
Price vs 200-day SMA	18.2%
Price vs 50-day SMA	8.44%
Relative volume	0
RSI	70.29
Sharpe ratio	0.7
Sortino ratio	1.38
Volume	1
Weekly RSI	65.02
YTD price change	17.61%
YTD total return	17.61%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	888.9M
Shares change (QoQ)	-0.25%
Shares change (YoY)	-0.62%
Shares held by insiders	0.17%
Shares held by institutions	89.36%
Short ratio	2.8 days

Deeper analysis on NEO/ZLLY

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NEO/ZLLY report

Is a complete NEO/ZLLY research report available?

No complete published report is available for neo/ZLLY (NEO/ZLLY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NEO/ZLLY (NEO/ZLLY)

Price

Financial snapshot

Fair-value bridge

Latest news · NEO/ZLLY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NEO/ZLLY indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NEO/ZLLY

Frequently asked questions